Who owns REVIVA PHARMACEUTICALS HOLDINGS, INC.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of RVPH from SEC Form 13F filings across 5 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 5 institutions disclosed 7,728 shares of REVIVA PHARMACEUTICALS HOLDINGS, INC. worth $676 — about 0.1% of shares outstanding; the largest disclosed holder is EMC Capital Management. Source: SEC Form 13F filings, parsed by EvidInvest.
5
13F holders
$676
value, 2026 filers
0.1%
of shares outstanding (7,728 sh)
3
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of RVPH's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | EMC Capital ManagementNEW | 6,696 | $3 | 0.0% | 0.1% | new |
| 2 | TD Waterhouse Canada Inc. | 625 | $412 | 0.0% | 0% | 0.0% |
| 3 | Purpose Unlimited Inc. | 405 | $259 | 0.0% | 0% | 0.0% |
| 4 | Miller Global Investments, LLCNEW | 1 | $1 | 0.0% | 0% | new |
| 5 | Mosley Wealth ManagementNEW | 1 | $1 | 0.0% | 0% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.